Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Annals of Internal Medicine|July 15, 1994
The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort StudyD S Stein, N M Graham, L P Park, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1991
Use of low-dose trimethoprim-sulfamethoxazole thrice weekly for primary and secondary prophylaxis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patientsD S Stein, R C Stevens, D Terry, et al.
Critical Care Medicine|May 25, 2001
Increased incidence of sepsis and altered monocyte functions in severely injured type A- glucose-6-phosphate dehydrogenase-deficient African American trauma patientsZ Spolarics, M Siddiqi, J H Siegel, et al.
Annals of Internal Medicine|June 15, 1996
Survival in HIV-infected patients who have received zidovudine: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Multicenter AIDS Cohort Study GroupN M Graham, D R Hoover, L P Park, et al.
Annals of Internal Medicine|March 13, 1999
Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258R M Gulick, V McAuliffe, J Holden-Wiltse, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2000
Single-dose pharmacokinetics of amprenavir, a human immunodeficiency virus type 1 protease inhibitor, in subjects with normal or impaired hepatic functionL Veronese, J Rautaureau, B M Sadler, et al.
The Journal of Infectious Diseases|August 11, 1998
Factors influencing the emergence of resistance to indinavir: role of virologic, immunologic, and pharmacologic variablesG L Drusano, J A Bilello, D S Stein, et al.
The Journal of Infectious Diseases|November 14, 1997
Predicting clinical progression or death in subjects with early-stage human immunodeficiency virus (HIV) infection: a comparative analysis of quantification of HIV RNA, soluble tumor necrosis factor type II receptors, neopterin, and beta2-microglobulin. Multicenter AIDS Cohort StudyD S Stein, R H Lyles, N M Graham, et al.
Annals of Internal Medicine|January 1, 1995
Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials GroupM A Fischl, K Stanley, A C Collier, et al.
The Journal of Infectious Diseases|April 1, 1991
Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected menW T Hughes, W Kennedy, J L Shenep, et al.
Pageof 10